Evidence map›Paper›PMID 29217155›Full record

ArticleBrain research2018

Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model.

Kerstin K Landrock, Patti Sullivan, Heidi Martini-Stoica, David S Goldstein, Brett H Graham, Shinya Yamamoto, Hugo J Bellen, Richard A Gibbs, Rui Chen, Marcello D'Amelio and 1 more

Open access · greenAbstract read
In one paragraph

Article in Brain research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. A novel, rapidly progressive ataxia due to a spontaneous Myo5a mutation in mice impairs transport proteins and alters mitochondria.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. CREB1ACS omega · 2021
    Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Kerstin K LandrockDepartment of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA. Electronic address: klandrock@tamu.edu.
Patti SullivanClinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA. Electronic address: psullivian@ninds.nih.gov.
Heidi Martini-StoicaInterdepartmental Program of Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: martinis@bcm.edu.
David S GoldsteinClinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA. Electronic address: goldsteind@ninds.nih.gov.
Brett H GrahamDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA. Electronic address: bgraham@bcm.edu.
Shinya YamamotoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA. Electronic address: yamamoto@bcm.edu.
Hugo J BellenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA. Electronic address: hbellen@bcm.edu.
Richard A GibbsDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA. Electronic address: rgibbs@bcm.edu.
Rui ChenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA. Electronic address: rchen@bcm.edu.
Marcello D'AmelioUniversity Campus Bio-Medico, Department of Medicine, Unit of Molecular Neurosciences, Rome, Italy. Electronic address: m.damelio@hsantalucia.it.
George StoicaDepartment of Veterinary Pathobiology, Texas A&M University, College Station, TX, USA. Electronic address: gstoica@cvm.tamu.edu.
Baylor College of Medicine · USNational Institute of Neurological Disorders and Stroke · USTexas A&M University · USUniversità Campus Bio-Medico · IT

Funding

Mechanisms of Parkinson Disease and Related DisordersZIANS003033 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI GOLDSTEIN, DAVID · 2009 to 2022
$8.2M
Succinyl-COA Synthetase Deficiency: A Model to Study Mitochondrial DNA (MTDNA) DeR01GM098387 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI GRAHAM, BRETT HARRISON · 2012 to 2016
$1.5M
Intramural NIH HHS ZIA NS003033NIGMS NIH HHS R01 GM098387
6 · The paper itself

Abstract

In this study, we analyze the neuropathological and biochemical alterations involved in the pathogenesis of a neurodegenerative/movement disorder during different developmental stages in juvenile rats with a mutant Myosin5a (Myo5a). In mutant rats, a spontaneous autosomal recessive mutation characterized by the absence of Myo5a protein expression in the brain is associated with a syndrome of locomotor dysfunction, altered coat color, and neuroendocrine abnormalities. Myo5a encodes a myosin motor protein required for transport and proper distribution of subcellular organelles in somatodendritic processes in neurons. Here we report marked hyperphosphorylation of alpha-synuclein and tau, as well as region-specific buildup of the autotoxic dopamine metabolite, 3,4-dihydroxyphenyl-acetaldehyde (DOPAL), related to decreased aldehyde dehydrogenases activity and neurodegeneration in mutant rats. Alpha-synuclein accumulation in mitochondria of dopaminergic neurons is associated with impaired enzymatic respiratory complex I and IV activity. The behavioral and biochemical lesions progress after 15 days postnatal, and by 30-40 days the animals must be euthanized because of neurological impairment. Based on the obtained results, we propose a pleiotropic pathogenesis that links the Myo5a gene mutation to deficient neuronal development and progressive neurodegeneration. This potential model of a neurodevelopmental disorder with neurodegeneration and motor deficits may provide further insight into molecular motors and their associated proteins responsible for altered neurogenesis and neuronal disease pathogenesis.

Indexed as

Heredodegenerative Disorders, Nervous System3,4-Dihydroxyphenylacetic Acidalpha-SynucleinAnimalsCentral Nervous SystemDisease Models, AnimalElectron Transport Chain Complex ProteinsMicroscopy, Electron, TransmissionMutationMyosin Heavy ChainsMyosin Type VPhosphorylationRatsRats, Mutant Strainstau Proteins3,4-dihydroxyphenylacetaldehyde3,4-Dihydroxyphenylacetic Acidalpha-SynucleinElectron Transport Chain Complex ProteinsMyo5a protein, ratMyosin Heavy ChainsMyosin Type Vtau ProteinsAutophagyDopamine metabolism alterationDying back neurodegenerationMitochondria complex I-IVMyo5a mutationTEMα-synuclein/tau-P

Identifiers

PMID29217155
PMCPMC7696654
OpenAlexW2773591216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.